Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Retargeting azithromycin-like compounds as antimalarials with dual modality (Study ST001315)

HILIC NEGATIVE ION MODE (Analysis AN002190)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14
sodium dodecyl sulfate	ME306978	0.07	0.15	0.09	0.11	0.11	12.48	0.10	0.10	0.10	0.11	0.09	0.15	0.13	0.20
PG(32:1)	ME307043	0.69	0.42	1.17	0.30	1.22	0.63	1.17	0.25	4.50	0.40	1.24	0.32	1.38	0.32
Orotate	ME307106	NA	0.24	NA	0.86	NA	0.69	0.96	0.41	0.31	3.20	NA	0.59	1.90	0.68
(S)-Dihydroorotate	ME307107	NA	0.58	0.58	0.71	0.81	0.54	0.90	1.03	0.85	2.43	0.80	0.92	1.95	0.52
Val-Val	ME306960	2.03	NA	NA	NA	NA	0.83	1.14	NA	NA	NA	0.54	1.05	0.94	0.58
2-Phospho-D-glycerate	ME307053	3.51	0.16	1.41	0.59	1.67	0.22	0.89	0.11	1.23	0.31	0.87	0.25	2.63	0.15
2-phosphono-3-sulfoproprionate	ME307033	2.45	0.20	1.34	0.54	1.49	0.21	0.86	0.11	1.00	0.77	0.75	0.21	2.08	0.18
4-Amino-4-deoxychorismate	ME306949	1.94	0.31	1.18	0.55	1.12	0.61	1.15	0.27	1.41	1.00	0.88	0.46	2.19	0.32
Citrate	ME307130	2.34	0.26	1.95	0.56	2.11	0.36	0.95	0.21	1.33	0.29	0.93	0.30	2.11	0.30
Phosphoenolpyruvate	ME307049	2.20	0.22	1.69	1.15	2.07	0.42	1.14	0.18	1.30	0.25	1.05	0.38	1.71	0.25
2^-azido-2^-deoxyuridine-5^-diphosphate	ME307151	2.85	0.15	2.05	0.49	1.79	0.31	1.25	0.27	1.23	0.13	1.03	0.41	1.15	0.14
GDP-mannose	ME306993	2.50	0.14	1.81	0.37	1.53	0.28	1.36	0.14	1.50	0.15	1.13	0.17	1.70	0.12
NADP+	ME307011	2.93	0.09	2.05	0.31	1.73	0.18	1.28	0.13	1.76	0.13	1.08	0.17	1.79	0.09
dGDP	ME306953	2.62	0.11	1.95	0.39	1.98	0.29	1.57	0.09	1.23	0.23	1.15	0.30	1.99	0.09
UDP	ME307153	2.96	0.07	1.71	0.30	1.68	0.30	1.31	0.07	1.20	0.27	1.00	0.22	2.22	0.06
CDP	ME307156	2.74	NA	1.17	0.14	1.15	0.28	0.80	NA	1.04	0.14	0.61	0.14	1.16	NA
fosmidomycin	ME307091	2.60	NA	1.01	NA	0.85	NA	0.50	NA	0.59	NA	0.23	NA	0.65	NA
GDP	ME306954	3.14	NA	1.22	0.19	0.91	0.17	0.59	NA	0.57	NA	0.41	NA	0.70	NA
6-formyl-H2-pterin	ME307138	1.81	0.46	1.26	0.52	1.01	NA	1.07	NA	0.81	0.92	0.86	0.45	1.22	NA
beta-Citryl-L-glutamic acid	ME306963	1.71	NA	1.40	0.10	1.02	NA	0.79	NA	0.97	NA	0.67	NA	1.04	NA
Hydroxymethylphosphonate	ME307162	4.19	0.22	1.75	0.35	1.45	0.29	1.11	0.17	1.33	0.33	0.86	0.31	1.38	0.24
p-aminobenzoyl glutamate	ME306973	4.34	0.33	1.07	0.59	1.09	0.37	1.24	0.31	0.81	0.52	1.11	0.44	1.39	0.40
Ala-Asp-Gly-Tyr	ME307001	2.88	0.29	1.16	0.59	0.65	0.69	1.34	0.73	NA	0.47	1.09	0.89	1.42	0.72
Pro-Thr-Ser-Ser	ME306992	2.21	0.59	0.98	0.51	0.38	0.33	1.07	0.67	NA	0.52	0.93	0.66	1.93	0.63
Ala-Ile-Ile-Lys	ME307016	2.90	0.59	1.27	0.69	1.24	0.62	1.14	0.53	1.09	0.62	0.95	0.66	1.18	0.52
Glu-Glu-Lys-Pro	ME307015	2.98	1.14	0.84	0.58	0.45	0.43	0.92	0.55	0.86	1.00	0.97	0.89	1.14	0.68
Ala-Ala-Ala	ME307157	NA	0.70	NA	1.26	NA	NA	0.38	NA	0.78	1.06	0.35	0.41	1.79	NA
Ile-Thr	ME306961	2.39	1.99	0.71	1.58	0.13	0.26	0.41	0.35	0.76	0.72	0.38	0.45	2.42	0.40
Gamma-Glutamyltyrosine	ME306982	1.36	0.97	0.87	2.10	0.23	0.18	0.33	0.17	1.11	0.68	0.27	0.33	2.49	0.14
Lys-Tyr	ME306990	1.07	0.63	0.59	1.23	NA	NA	NA	NA	0.76	0.30	NA	NA	1.96	NA
Ile-Lys	ME306977	1.32	1.12	0.67	1.59	NA	NA	0.43	NA	0.94	0.63	0.33	0.32	2.12	0.18
N-Acetyl-L-citrulline	ME307143	1.00	0.84	0.58	1.09	NA	NA	0.31	NA	0.84	0.86	0.26	0.20	2.26	NA
N-hydroxy DAP	ME307136	1.23	0.92	0.96	1.43	0.40	0.28	0.71	0.55	1.11	0.77	0.53	0.41	3.36	0.35
Lys-Ser	ME307160	1.89	1.06	1.12	1.96	0.55	0.53	0.65	0.42	1.41	0.56	0.71	0.72	1.89	0.53
Gln-Ser	ME307144	1.37	1.19	0.86	1.45	0.48	0.46	0.77	0.54	1.01	1.37	0.56	0.58	2.59	0.56
N6-Acetyl-N6-hydroxy-L-lysine	ME307145	1.54	1.07	0.73	1.64	0.25	0.34	0.72	0.44	0.79	0.99	0.55	0.65	2.13	0.60
FA oxo(7:0)	ME307133	1.90	2.37	0.78	0.85	0.86	0.86	0.79	0.79	0.86	0.76	0.75	0.89	0.74	0.81
Ile-Val	ME306971	1.56	2.44	0.61	1.05	0.46	0.38	0.64	0.96	0.47	1.67	0.59	0.78	1.06	0.77
DG(34:1)	ME307040	NA	1.42	0.32	0.85	0.65	0.95	NA	1.07	NA	0.90	NA	1.18	NA	0.97
PA(32:0)	ME307036	NA	1.15	0.26	0.73	1.36	0.97	1.16	0.77	NA	1.17	1.55	1.00	0.97	0.92
PE(31:4)	ME307037	NA	1.13	0.30	0.92	0.62	0.94	0.60	1.12	NA	1.10	1.05	1.15	0.45	1.41
FA hydroxy(16:0)] hexadecanoic acid	ME306996	0.53	1.07	0.69	0.85	0.74	3.34	0.50	1.23	0.74	0.71	0.67	0.82	0.87	1.11
[FA (18:1)] 9Z-octadecenoic acid	ME307002	0.74	0.58	1.06	0.78	1.25	2.03	1.31	0.64	0.78	0.72	1.33	0.80	1.23	0.74
FA (19:1)	ME307004	0.79	0.53	1.03	0.45	1.02	2.98	1.39	0.65	0.48	0.53	1.00	0.98	1.16	0.84
Ala-Ala-Asp-Tyr	ME307003	NA	NA	0.75	0.50	1.12	1.23	1.17	0.70	0.58	0.80	1.22	0.67	1.52	0.38
L-Cystine	ME307122	1.14	0.73	1.32	2.44	0.93	0.56	0.38	0.64	1.04	1.14	0.79	0.69	1.20	1.01
2-Hydroxy-2,4-pentadienoate	ME307108	0.63	0.84	1.01	1.85	1.18	0.95	0.55	0.98	1.04	1.34	1.03	0.78	0.80	1.04
D-Erythrose	ME307098	0.70	0.96	0.91	1.82	1.16	0.88	0.47	0.99	1.04	1.33	1.07	0.86	0.71	1.11
FA dioxo(10:0)	ME306955	0.68	1.04	0.82	0.85	1.64	1.46	0.56	1.16	0.50	1.05	1.08	0.92	0.95	1.07
[FA hydroxy(11:2/11:2)] 2R,9R-dihydroxy-3S,4S,7S,8S-diepoxy-5E,10-undecadien-1-ol	ME306965	0.64	1.16	1.06	0.73	1.55	1.29	NA	0.77	0.84	0.85	1.25	1.38	0.72	0.92
Phytuberin	ME306997	0.81	1.48	1.11	0.43	0.95	1.95	1.05	0.59	1.49	1.00	1.18	0.73	0.84	0.70
Rishitin	ME306984	0.83	1.45	1.05	0.47	1.06	1.49	0.99	0.66	1.39	1.21	1.12	0.74	0.83	0.71
[ST (12:0) homo-seco-cholestatrien-tetrol	ME307031	0.94	1.00	1.00	0.95	0.96	0.85	0.75	0.96	0.86	1.05	2.19	1.08	0.57	0.85
Lys-Lys-Val-Val	ME307018	1.31	1.03	0.91	0.92	0.79	1.33	0.79	1.13	1.14	0.53	0.84	1.09	1.00	1.19
Zinnimidine	ME306987	1.03	1.00	1.08	0.82	0.87	1.26	0.91	1.24	0.63	0.75	1.08	1.17	0.89	1.14
D-Galactose	ME307123	0.51	0.96	0.83	0.89	1.09	1.16	1.23	0.76	0.74	1.63	0.85	0.97	1.40	0.97
2,7-Anhydro-alpha-N-acetylneuraminic acid	ME306966	0.97	0.94	0.88	0.84	0.89	0.92	1.06	0.90	1.05	1.26	1.06	0.94	1.43	0.82
(R)-2-Hydroxyglutarate	ME307113	0.64	1.01	0.79	1.03	0.99	0.98	1.16	0.82	0.89	1.20	1.05	1.15	1.43	0.88
(S)-Lactate	ME307050	0.90	0.88	1.08	1.46	1.11	0.83	1.00	0.87	0.88	1.00	0.84	1.01	1.13	1.01
4-Hydroxyphenylglyoxylate	ME307148	1.00	1.11	1.09	0.85	1.06	0.89	1.01	0.98	0.97	1.11	0.96	0.88	1.22	0.88
Hydroxypyruvate	ME307048	0.94	0.98	1.05	0.92	1.06	1.01	0.98	0.98	1.02	1.11	0.97	0.98	1.03	0.96
Sulfate	ME307163	1.35	0.88	1.06	0.99	1.05	0.98	0.84	0.95	1.07	0.96	0.85	0.92	1.12	1.00
Oxalate	ME307032	1.16	0.88	0.95	1.02	1.05	0.90	0.98	0.89	1.08	0.93	0.98	1.01	1.16	1.01
(R,R)-Tartaric acid	ME307095	1.09	0.94	1.05	0.95	0.99	0.93	0.94	1.00	1.03	1.01	0.99	0.98	1.11	1.00
[SP (16:0)] N-(hexadecanoyl)-sphing-4-enine	ME307035	0.50	0.83	0.60	1.13	0.69	0.91	0.87	0.89	1.07	1.68	1.23	1.12	0.99	1.16
TG(61:11)	ME307116	0.46	0.93	0.73	0.87	0.52	1.23	1.06	0.93	0.74	1.19	1.61	1.27	0.81	1.19
D-Mannitol 1-phosphate	ME307128	0.71	1.01	0.75	1.35	0.82	1.14	0.92	0.74	0.99	1.33	0.88	1.31	1.20	0.85
PI(40:5)	ME307089	0.89	1.17	0.80	1.01	0.82	1.12	1.16	0.84	0.80	1.08	1.19	1.10	0.84	1.11
PS(O-20:0/0:0)	ME307028	0.90	1.08	0.97	1.06	0.89	1.02	0.92	0.99	0.96	1.03	0.94	1.07	1.04	1.13
PA(P-42:4)	ME307078	0.76	1.11	0.96	1.11	0.83	1.12	0.88	1.07	0.91	1.18	0.88	1.11	0.98	1.10
SM(d18:0/24:1(15Z)(OH))	ME307088	0.81	1.13	0.80	1.09	0.86	1.07	0.92	0.99	0.87	1.17	0.96	1.16	0.91	1.11
Lys-Lys-Met-Val	ME307019	0.60	1.02	0.87	1.12	1.05	1.07	0.95	1.09	0.84	1.21	1.15	1.06	0.90	1.08
PE(38:5)	ME307068	0.54	1.07	0.95	1.06	1.00	1.05	1.05	0.93	1.04	1.06	1.03	1.10	0.99	1.13
PE(O-38:5)	ME307069	0.38	1.32	0.88	1.17	0.96	1.08	0.91	1.06	0.96	1.17	1.07	1.18	0.66	1.19
PS(38:4)	ME307074	0.37	1.06	0.90	1.08	0.94	1.11	1.09	0.88	0.99	1.11	1.25	1.13	1.02	1.06
PE(34:1)	ME307047	0.36	1.15	0.82	1.05	0.84	1.15	1.15	0.99	0.88	1.10	1.31	1.13	0.95	1.13
PS(40:5)	ME307083	0.30	1.18	0.78	1.15	0.82	1.21	1.07	0.92	0.91	1.13	1.23	1.21	0.97	1.12
PE(36:1)	ME307062	0.51	1.20	0.68	1.05	0.77	1.22	1.06	1.00	0.71	1.15	1.33	1.18	0.86	1.13
PI(36:1)	ME307080	0.31	1.29	0.64	1.03	0.66	1.24	1.17	0.94	0.65	1.14	1.38	1.17	0.94	1.19
4-Hexyloxyphenol	ME306974	0.46	1.12	0.92	0.57	1.10	1.02	1.32	0.59	1.54	1.20	1.79	0.85	0.98	0.55
IMP	ME306950	1.01	0.59	1.19	0.80	1.36	0.88	1.32	0.45	1.30	0.91	1.28	0.93	1.43	0.54
L-gamma-glutamyl-L-isoleucine	ME306967	1.08	0.57	1.16	0.60	1.29	0.66	1.50	0.48	1.30	0.88	1.43	0.68	1.73	0.48
sn-Glycerol 3-phosphate	ME307055	0.85	0.92	1.19	0.80	1.50	0.61	1.26	0.58	1.20	0.82	1.26	0.71	1.53	0.77
D-Ribose 5-phosphate	ME307103	0.92	0.67	1.13	0.90	1.44	0.58	1.30	0.50	1.14	0.91	1.23	0.77	1.90	0.60
L-beta-aspartyl-L-leucine	ME306958	0.91	0.55	1.20	0.83	1.21	0.53	1.33	0.68	0.95	1.04	1.32	0.86	1.79	0.57
DG(34:3)	ME307038	1.11	0.63	1.15	0.71	1.15	0.44	1.21	0.71	1.47	0.71	1.61	0.74	1.36	0.79
D-myo-Inositol 1,2-cyclic phosphate	ME307119	1.07	0.65	0.95	0.72	1.11	0.68	1.22	0.56	1.79	1.04	1.26	0.80	1.57	0.58
[PG (18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1^-sn-glycerol)	ME307024	1.05	0.68	1.07	0.80	1.11	0.83	1.27	0.62	1.64	0.86	1.20	0.84	1.27	0.77
phosphinomethylisomalate	ME307115	1.02	0.70	1.15	0.68	1.26	0.69	1.30	0.66	1.50	0.85	1.29	0.82	1.36	0.70
PI(36:4)	ME307076	1.01	0.70	1.15	0.83	1.52	0.84	1.06	0.80	1.37	0.78	1.39	0.80	0.96	0.78
3-Propylmalate	ME307134	1.18	0.76	1.15	0.92	1.21	0.78	1.18	0.71	1.10	0.90	1.17	0.83	1.33	0.77
5-Pyridoxolactone	ME307149	1.16	0.78	1.15	0.83	1.09	0.88	1.24	0.79	1.07	0.88	1.18	0.79	1.35	0.82
(S)-2-Aceto-2-hydroxybutanoate	ME307118	1.29	0.78	1.25	0.74	1.32	0.77	1.16	0.68	1.34	0.75	1.18	0.73	1.28	0.73
Ala-Lys-Met-Trp	ME307025	1.33	0.66	1.31	0.91	1.26	0.79	1.23	0.66	1.25	0.73	1.08	0.75	1.37	0.66
Orthophosphate	ME307164	1.29	0.71	1.22	0.88	1.19	0.80	1.15	0.78	1.26	0.78	1.06	0.86	1.28	0.73
Cholesterolsulfate	ME307029	0.60	0.75	1.13	0.86	1.20	1.35	1.11	0.64	1.11	0.75	1.15	1.37	1.19	0.78
FA hydroxy(10:0)	ME306962	0.79	0.96	1.03	0.89	1.37	1.21	1.06	1.02	0.83	0.78	1.00	1.11	1.02	0.93
[FA (22:5)] 7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid	ME307017	0.70	0.75	1.12	0.95	1.38	1.15	1.17	0.79	0.80	0.75	1.22	0.92	1.25	0.97
Icosatrienoic acid	ME307008	0.60	0.69	1.12	0.83	1.42	1.37	1.26	0.67	0.92	0.70	1.35	0.86	1.36	0.85
DG(36:3)	ME307044	0.72	0.74	1.15	0.86	1.35	0.78	1.30	0.70	1.00	0.71	1.66	0.78	1.34	0.81
FA (20:4)	ME307007	0.81	0.58	1.27	0.84	1.44	0.79	1.43	0.65	0.90	0.67	1.58	0.82	1.39	0.78
PE(34:3)	ME307045	0.77	0.62	1.26	0.85	1.03	0.93	1.41	0.73	1.49	0.65	1.28	0.88	1.26	0.85
PI(36:2)	ME307079	0.43	0.83	1.12	0.80	1.17	0.83	1.46	0.65	1.27	0.77	1.70	0.85	1.30	0.81
PS(36:2)	ME307063	0.48	0.86	1.14	0.84	1.17	0.89	1.29	0.70	1.23	0.89	1.48	0.88	1.29	0.87
PI(36:3)	ME307077	0.73	0.71	1.15	0.74	1.24	0.86	1.24	0.74	1.37	0.79	1.53	0.72	1.34	0.73
PI(38:5)	ME307085	0.78	0.73	1.12	0.80	1.28	0.89	1.30	0.73	1.22	0.78	1.47	0.83	1.20	0.80
PS(38:6)	ME307072	0.64	0.69	1.32	0.80	1.42	0.81	1.24	0.69	1.28	0.78	1.35	0.86	1.36	0.77
PS(O-36:1)	ME307066	0.84	0.75	1.28	0.82	1.21	0.83	1.22	0.73	1.16	0.83	1.24	0.82	1.38	0.88
[PI(18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1^-myo-inositol)	ME307030	0.92	0.78	1.07	0.93	1.09	0.92	1.17	0.69	1.19	0.96	1.37	0.88	1.22	0.81
PA(34:2)	ME307039	0.73	0.84	0.97	0.83	1.04	0.80	1.29	0.66	1.52	0.87	1.37	0.84	1.38	0.77
PE(32:1)	ME307042	0.70	0.87	1.13	0.80	1.13	0.78	1.28	0.75	1.33	0.87	1.35	0.91	1.37	0.72
PS(40:7)	ME307081	0.62	0.82	1.13	1.01	1.37	0.93	1.03	0.99	1.09	0.98	1.28	0.93	0.92	0.89
PE(36:3)	ME307060	0.56	0.94	1.13	0.93	1.12	0.95	1.17	0.87	1.09	0.96	1.16	0.92	1.13	0.90
PE(36:4)	ME307059	0.62	0.95	1.11	0.91	1.13	0.94	1.12	0.87	1.18	0.97	1.16	0.97	1.13	0.96
PE(36:5)	ME307058	0.69	1.00	1.10	0.96	1.14	0.94	1.08	0.85	1.14	0.94	1.12	0.94	1.12	0.99
[FA (11:0)] undecanoic acid	ME306972	0.51	1.07	1.07	0.99	1.10	1.04	1.47	0.78	1.06	0.91	1.33	0.79	1.03	0.84
PA(34:1)	ME307041	0.57	1.03	0.73	0.93	0.87	1.02	1.18	0.74	1.12	1.12	1.47	1.04	1.08	0.96
PE(36:2)	ME307061	0.52	0.93	1.17	0.96	0.88	0.94	1.13	0.90	1.13	0.96	1.38	0.98	1.20	0.93
PI(38:4)	ME307086	0.59	0.89	1.01	0.94	1.07	0.91	1.25	0.81	0.98	1.00	1.47	0.96	1.08	0.92
PI(34:1)	ME307070	0.38	0.93	0.94	0.92	1.03	0.97	1.31	0.77	1.14	0.95	1.54	1.00	1.16	0.95
PS(40:6)	ME307082	0.43	0.95	0.99	1.00	1.04	1.04	1.19	0.81	1.05	1.01	1.36	1.01	1.14	0.97
Adrenochrome	ME307161	0.89	1.02	0.93	0.78	1.17	0.87	1.02	0.92	1.19	0.88	1.45	1.06	1.12	0.68
PE(38:6)	ME307067	0.82	1.00	0.65	0.94	1.12	1.14	1.12	0.82	1.13	0.87	1.18	0.99	1.20	0.97
demethyl-phosphinothricin	ME307090	1.14	0.89	1.43	0.79	1.29	0.87	1.70	0.41	0.96	0.81	1.52	0.58	1.23	0.90
LysoPE(20:4)	ME307026	0.86	0.32	1.18	0.49	1.58	0.90	1.31	0.75	1.16	0.70	1.76	0.61	1.37	0.69
PS(38:7)	ME307071	1.12	0.38	1.23	1.01	1.90	0.89	1.36	0.68	1.01	0.89	1.45	0.73	1.06	0.78
N-α-acetyl lysine methyl ester	ME307158	1.30	0.33	0.69	0.62	1.04	0.52	2.11	0.29	0.18	0.30	2.18	0.93	0.92	0.22
Dihydrozeatin-O-glucoside	ME306994	0.71	NA	0.83	0.37	0.84	1.00	1.70	1.17	NA	0.70	1.51	0.94	0.73	1.25
Ala-Leu-Trp-Ser	ME307021	1.71	0.70	0.83	0.76	0.61	0.99	1.44	0.87	NA	0.41	1.16	1.38	0.99	1.14
Gammaglutamylornithine	ME306959	1.50	0.22	0.94	0.41	1.27	1.19	1.84	1.06	0.30	0.46	1.81	1.30	0.68	1.04
Hydantoin-5-propionate	ME307129	1.82	0.35	0.92	0.44	0.90	1.10	1.91	0.93	0.21	0.46	1.75	1.26	0.94	1.00
N-gamma-Acetyldiaminobutyrate	ME307120	1.56	0.52	0.76	1.44	0.51	NA	1.41	0.70	0.31	0.64	1.19	0.72	1.30	0.79
N5-formyl-N5-hydroxy-L-ornithine	ME307121	0.80	0.36	0.57	1.17	0.72	0.74	1.53	1.23	0.56	0.94	1.01	1.25	1.45	0.79
N-Acetylornithine	ME307135	1.62	0.74	0.77	0.78	0.63	0.88	1.26	0.72	0.67	1.13	1.03	1.18	1.55	0.82
Met-Cys-Cys	ME306970	1.49	0.41	0.98	1.32	1.08	0.81	1.46	0.48	0.79	0.71	1.56	0.96	1.36	0.59
Norophthalmicacid	ME306956	1.55	0.81	1.01	0.94	1.04	0.63	1.38	0.69	0.82	0.73	1.20	0.74	1.72	0.72
(S)-AMPA	ME307131	1.66	NA	1.15	0.30	1.21	0.91	1.60	0.59	0.78	0.29	1.39	0.89	1.45	0.77
Glutamylalanine	ME307140	1.42	0.37	0.95	0.65	1.02	0.87	1.88	0.93	0.58	0.56	1.56	0.95	1.23	0.87
Gly-Ser	ME307101	1.33	0.53	1.39	0.94	1.02	0.72	1.70	0.79	0.54	0.42	1.71	0.85	1.34	0.73
Lys-Gly	ME307147	1.02	0.40	1.39	0.97	1.10	0.94	1.85	0.80	0.30	0.57	1.54	1.13	1.26	0.75
2-C-Methyl-D-erythritol 4-phosphate	ME307104	1.16	0.35	1.60	1.66	1.83	0.45	0.55	0.32	1.59	0.83	1.76	0.45	1.29	0.16
Ala-Leu-Thr-Ala	ME306995	1.04	0.67	1.07	0.67	0.98	0.50	1.02	0.44	2.37	1.09	1.01	0.60	2.06	0.47
PG(38:4)	ME307075	0.59	0.71	1.29	0.67	1.29	0.67	1.25	0.55	2.15	0.71	1.44	0.67	1.36	0.65
PG(38:5)	ME307073	0.65	0.67	1.32	0.61	1.31	0.58	1.28	0.53	2.27	0.70	1.42	0.66	1.37	0.61
PG(36:1)	ME307065	0.43	0.92	0.98	0.71	1.10	0.72	1.16	0.58	2.56	0.85	1.32	0.75	1.20	0.72
PG(40:5)	ME307084	0.72	0.95	0.98	0.79	1.14	0.79	1.03	0.68	2.02	0.89	1.19	0.81	1.15	0.78
PG(33:1)	ME307046	0.87	0.48	1.22	0.40	1.34	0.41	1.16	0.34	3.51	0.48	1.36	0.49	1.45	0.43
PG(34:2)	ME307056	0.75	0.43	1.49	0.40	1.46	0.42	1.49	0.31	2.72	0.44	1.58	0.40	1.72	0.40
PG(34:1)	ME307057	0.58	0.62	1.23	0.52	1.28	0.51	1.30	0.42	2.95	0.60	1.46	0.54	1.48	0.52
PG(36:2)	ME307064	0.62	0.61	1.29	0.55	1.28	0.53	1.32	0.44	2.66	0.64	1.43	0.56	1.50	0.57
[FA trihydroxy(4:0)] 2,3,4-trihydroxy-butanoic acid	ME307099	0.44	0.34	1.08	0.38	2.23	0.51	1.84	0.49	0.76	1.19	1.36	0.48	2.36	0.36
Succinate	ME307093	0.64	0.35	1.29	0.48	2.24	0.68	1.87	0.46	0.80	0.73	1.58	0.68	1.67	0.51
2-Oxoglutarate	ME307109	0.51	0.16	1.39	0.47	2.40	0.76	2.40	0.31	0.89	0.54	1.75	0.68	1.42	0.30
D-Gluconic acid	ME307124	0.60	0.22	1.55	0.49	2.47	0.48	2.10	0.26	1.06	0.47	1.78	0.46	1.92	0.14
Fumarate	ME307092	0.61	0.23	1.66	0.39	2.31	0.48	2.22	0.35	0.72	0.57	1.84	0.49	1.79	0.33
(S)-Malate	ME307094	0.59	0.18	1.69	0.34	2.35	0.43	2.33	0.27	0.70	0.54	1.88	0.45	1.93	0.30
CMP	ME307155	1.18	0.25	1.21	0.36	1.72	0.80	1.70	0.27	1.64	0.79	1.57	0.67	1.38	0.22
UMP	ME307150	0.88	0.15	1.28	0.28	1.90	0.85	2.22	0.16	1.30	0.66	1.86	0.66	1.60	0.20
L-alpha-Amino-gamma-oxalylaminobutyric acid	ME307117	0.51	0.24	1.66	0.77	1.56	0.73	1.85	0.68	0.51	0.61	1.80	0.85	1.69	0.54
Asp-Leu-Lys-Asp	ME307009	1.25	0.27	1.51	0.51	1.74	0.70	1.94	0.57	0.38	0.42	1.73	0.55	1.81	0.61
GMP	ME306952	1.33	0.14	1.47	0.43	1.94	0.76	1.77	0.23	0.99	0.65	1.66	0.60	1.57	0.21
5-6-Dihydrouridine	ME307154	1.10	0.35	1.51	0.67	1.65	0.58	1.65	0.40	1.03	0.46	1.78	0.68	1.68	0.46
CMP-2-aminoethylphosphonate	ME306968	1.13	0.39	1.45	0.51	1.51	0.49	1.82	0.35	1.03	0.54	1.71	0.56	2.09	0.43
Asp-Met-Pro-Ser	ME306999	0.82	0.26	1.14	0.50	1.42	0.27	1.29	0.45	1.25	1.33	1.12	0.43	2.22	0.45
5-Oxoproline	ME307110	0.68	0.47	1.20	0.73	1.52	0.96	1.15	0.40	1.06	1.20	1.22	0.60	2.29	0.53
N-Carbamoyl-L-aspartate	ME307111	0.72	0.35	1.03	0.96	1.12	0.81	1.03	0.61	0.86	1.70	1.03	0.84	2.32	0.62
Ala-Met-Asp-Tyr	ME307012	0.60	0.34	1.08	0.52	1.29	0.23	2.03	0.22	1.97	1.06	1.47	0.30	2.31	0.34
furaneol glucopyranoside	ME306975	0.43	0.36	0.87	0.49	1.21	0.53	1.74	0.71	1.54	0.93	1.97	0.56	1.60	0.55
L-Threonine	ME307100	1.24	0.43	1.87	0.44	1.17	0.44	1.61	0.40	1.40	0.42	0.59	0.47	2.97	0.53
Glycerone phosphate	ME307052	1.39	0.96	1.21	1.49	0.86	0.37	0.89	0.44	1.40	0.61	1.06	0.51	1.68	1.14
D-Fructose 6-phosphate	ME307125	1.61	1.07	1.47	0.98	1.03	0.49	1.17	0.48	1.20	0.71	1.19	0.51	1.68	0.42
D-Glucose 6-phosphate	ME307126	1.75	1.03	1.49	0.92	1.01	0.40	0.96	0.47	1.24	0.74	1.10	0.52	1.84	0.53
Glu-Ser	ME307142	1.18	0.59	1.22	0.66	1.13	0.42	1.46	0.48	1.06	0.78	1.57	0.59	2.24	0.62
CMP-N-trimethyl-2-aminoethylphosphonate	ME306986	1.08	0.41	1.27	0.58	1.19	0.56	1.55	0.43	1.29	0.94	1.30	0.64	2.38	0.39
L-Aspartate	ME307096	1.10	0.66	1.30	0.74	0.98	0.51	1.52	0.41	1.43	0.68	1.32	0.64	2.19	0.51
L-Asparagine	ME307097	1.14	0.79	1.21	1.23	0.90	0.49	1.09	0.47	1.48	0.80	1.03	0.60	2.18	0.58
L-Serine	ME307051	0.98	0.76	1.28	1.06	0.92	0.68	1.36	0.48	1.25	0.62	1.25	0.73	1.97	0.68
sn-glycero-3-Phosphoethanolamine	ME307105	1.71	0.74	1.14	0.55	0.95	0.52	1.80	0.44	1.38	0.53	1.51	0.60	1.56	0.58
D-Sedoheptulose 7-phosphate	ME307137	1.60	0.60	1.37	0.60	1.18	0.47	1.34	0.35	1.52	0.70	1.37	0.60	1.97	0.35
L-Glutamate	ME307114	1.65	0.41	1.22	0.66	1.29	0.60	1.53	0.50	1.21	0.64	1.39	0.69	1.67	0.55
[PG (16:0)] 1-hexadecanoyl-sn-glycero-3-phospho-(1^-sn-glycerol)	ME307020	1.42	0.49	1.29	0.63	1.20	0.61	1.45	0.48	1.53	0.61	1.35	0.68	1.63	0.62
[PG (18:1)] 1-(9E-octadecenoyl)-sn-glycero-3-phospho-(1^-sn-glycerol)	ME307023	1.44	0.49	1.29	0.67	1.23	0.62	1.40	0.53	1.67	0.64	1.27	0.67	1.46	0.64
N-Acetyl-aspartyl-glutamate	ME306964	1.38	0.21	1.35	0.50	1.47	0.35	1.46	0.39	1.54	0.44	1.48	0.38	2.30	0.28
UDP-glucose	ME306991	1.60	0.22	1.43	0.62	1.51	0.40	1.33	0.23	1.77	0.51	1.35	0.40	2.42	0.22
CDP-ethanolamine	ME306969	1.35	0.31	1.36	0.52	1.46	0.48	1.61	0.30	1.96	0.49	1.61	0.53	1.70	0.33
UDP-N-acetyl-D-galactosamine	ME306998	1.38	0.29	1.43	0.56	1.48	0.43	1.64	0.21	1.82	0.39	1.65	0.47	2.01	0.23
Deamino-NAD+	ME307010	1.37	0.29	1.38	0.67	1.53	0.58	1.39	0.38	1.69	0.65	1.37	0.49	1.75	0.26
Cyclic ADP-ribose	ME306988	1.31	0.39	1.41	0.56	1.50	0.52	1.54	0.35	1.67	0.58	1.52	0.61	1.70	0.35
Sinalbin	ME306983	1.21	0.39	1.33	0.65	1.66	0.45	1.47	0.46	1.52	0.56	1.58	0.55	1.68	0.31
Bile salt	ME307022	1.46	0.41	1.40	0.56	1.60	0.42	1.64	0.40	1.32	0.51	1.47	0.48	1.69	0.44
D-4^-Phosphopantothenate	ME307159	1.53	0.41	1.37	0.49	1.58	0.38	1.57	0.28	1.51	0.53	1.60	0.44	2.01	0.31
Glycerophosphoglycerol	ME307127	1.28	0.25	1.59	0.32	1.39	0.26	2.02	0.27	2.46	0.29	1.09	0.27	2.07	0.19
2-Deoxy-D-ribose 5-phosphate	ME307102	1.16	0.22	1.45	0.31	1.43	0.26	1.66	0.23	2.15	0.54	1.34	0.23	2.56	0.20
gamma-L-Glutamyl-L-cysteine	ME307141	1.09	0.25	1.57	0.65	1.21	0.45	1.69	0.28	2.17	0.46	1.32	0.35	2.33	0.18
Glutathione disulfide	ME307006	1.63	0.11	1.89	0.35	1.45	0.23	2.07	0.27	1.31	0.30	1.65	0.29	2.17	0.28
O-Phospho-L-serine	ME307054	1.32	0.10	1.49	0.14	1.57	0.11	1.58	0.12	1.27	0.28	1.54	0.17	2.18	NA
N-Succinyl-L-glutamate	ME307152	1.52	0.15	1.72	0.31	1.95	0.23	1.57	0.15	1.90	0.28	1.49	0.25	2.34	0.14
Glutathione	ME306957	1.15	0.09	2.23	0.31	1.61	0.26	2.13	0.22	1.56	0.22	1.33	0.25	2.49	0.15
N-Acetyl-L-glutamate	ME307132	1.23	0.13	1.95	0.25	1.78	0.17	1.97	0.16	1.99	0.22	1.26	0.17	2.59	0.14
Ethanolamine phosphate	ME307034	0.95	0.13	1.67	0.26	1.68	0.26	2.20	0.21	1.31	0.26	2.05	0.32	2.47	0.24
N-Acetyl-D-mannosaminolactone	ME307139	0.88	0.13	1.76	0.46	1.83	0.34	2.06	0.21	1.07	0.30	2.24	0.37	2.22	0.14
Asp-Cys-Cys-Ser	ME306981	0.95	0.21	1.60	0.67	1.53	0.28	0.94	0.29	0.97	0.38	1.52	0.29	2.72	0.26
Kinobscurinone	ME307000	0.78	0.20	1.55	0.59	1.38	0.45	1.68	0.50	1.21	0.45	1.69	0.48	2.48	0.20
Glu-Glu-Gln-His	ME307013	NA	NA	1.52	0.64	NA	NA	1.43	0.66	NA	NA	0.87	0.34	1.09	NA
Trp-Gly	ME306979	NA	NA	0.61	NA	1.29	0.66	1.90	NA	NA	0.40	1.54	0.65	0.41	0.70
Cys-Leu-Cys-Tyr	ME307014	NA	0.31	0.92	0.57	1.60	NA	1.39	NA	1.05	0.98	1.09	0.47	1.30	0.21
Mukaadial	ME306989	0.42	NA	0.84	NA	1.95	NA	1.11	NA	1.38	NA	1.12	NA	0.89	NA
Cys-Phe-Cys-Gln	ME307005	NA	NA	0.72	NA	0.84	NA	1.07	NA	1.13	0.55	0.81	NA	1.43	NA
ferric dicitrate	ME306976	0.22	NA	0.89	NA	1.01	NA	0.85	NA	1.46	NA	0.64	NA	1.17	NA
Chenodeoxyglycocholate	ME307027	1.03	NA	0.97	NA	1.27	NA	1.12	0.29	0.97	0.30	1.40	NA	1.17	0.38
Guanosine	ME306951	0.43	NA	0.78	NA	1.23	NA	1.37	NA	0.65	0.57	0.87	NA	1.21	NA
(R)-S-Lactoylglutathione	ME306980	0.65	NA	1.10	0.17	1.04	NA	1.20	NA	0.76	NA	1.15	0.19	1.64	NA

Factors:

F1	treatment:azithromycin \| Experiment:1
F2	treatment:azithromycin \| Experiment:2
F3	treatment:Chloroquine \| Experiment:1
F4	treatment:Chloroquine \| Experiment:2
F5	treatment:Dihydroartemisinin \| Experiment:1
F6	treatment:Dihydroartemisinin \| Experiment:2
F7	treatment:Ethanol control \| Experiment:1
F8	treatment:Ethanol control \| Experiment:2
F9	treatment:GSK5 \| Experiment:1
F10	treatment:GSK5 \| Experiment:2
F11	treatment:GSK66 \| Experiment:1
F12	treatment:GSK66 \| Experiment:2
F13	treatment:GSK71 \| Experiment:1
F14	treatment:GSK71 \| Experiment:2

Data matrix